We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look ...
TD Cowen has downgraded Merck (NYSE:MRK) to hold from buy, citing Keytruda's impending loss of market exclusivity, or LOE. The bank said it no longer sees "viable arguments" for outperformance in the ...
TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...
1h
MarketBeat on MSNMerck: 4 No-Brainer Reasons to Buy This DipBig pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the ...
There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results